Strategy
Many new and existing drugs have enormous therapeutic potential, yet key physical properties that can drive efficacy are not ideal. Recent developments in solid form control, such as cocrystallisation, offer the possibility to solve such problems to create new and enhance existing drug products.
Nuformix’s approach creates new drug forms that satisfy three key criteria:
- Physical properties are better tuned towards specific product requirements
- Protected by substance of matter patents
- Subject to low product approval and regulatory barriers
Nuformix is currently seeking partners for developing its growing product portfolio whilst sustaining an aggressive product development pipeline.